Specificity of blebbistatin, an inhibitor of myosin II |
| |
Authors: | John Limouze Aaron F. Straight Timothy Mitchison James R. Sellers |
| |
Affiliation: | (1) Laboratory of Molecular Cardiology, National Heart, Lung and Blood Institute, National Institutes of Health, MD, USA;(2) Institute for Chemistry and Cell Biology, Harvard Medical School, 250 Longwood Avenue, MA, USA |
| |
Abstract: | Blebbistatin is a small molecule inhibitor discovered in a screen for inhibitors of nonmuscle myosin IIA. We have examined the specificity and potency of the drug by assaying its effects on the actin-activated MgATPase assay of diverse members of the myosin superfamily. Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 values ranging from 0.5 to 5 μM. Interestingly, smooth muscle which is highly homologous to vertebrate nonmuscle myosin is only poorly inhibited (IC50=80 μM). The drug potently inhibits Dictyostelium myosin II, but poorly inhibits Acanthamoeba myosin II. Blebbistatin did not inhibit representative myosin superfamily members from classes I, V, and X. This revised version was published online in July 2006 with corrections to the Cover Date. |
| |
Keywords: | myosin blebbistatin inhibitors |
本文献已被 PubMed SpringerLink 等数据库收录! |
|